Search references for GPR139. Phrases containing GPR139
See searches and references containing GPR139!GPR139
Protein-coding gene in the species Homo sapiens
G-protein coupled receptor 139 (GPR139) is a G protein-coupled receptor that in humans is encoded by the GPR139 gene. It is coupled to the Gq/11 pathway
GPR139
Drug increasing motivation in humans
of agomelatine in humans has been questioned and is controversial. The GPR139 agonist zelatriazin (TAK-041; NBI-1065846) has shown pro-motivational effects
Motivation-enhancing_drug
Group of biological receptors
derived from hybridization of two or more of the known opioid receptors. GPR139 has been identified as a novel opioid receptor, specifically of dynorphins
Opioid_receptor
Opioid peptide
κ-opioid receptor (KOR). It produces one of the strongest responses at GPR139 receptor among dynorphins. Additionally, it uniquely modulates NMDA receptor
Big_dynorphin
Chemical compound
Zelatriazin (NBI-1065846 or TAK-041) is a small-molecule agonist of GPR139. It was developed for schizophrenia and anhedonia in depression, but trials
Zelatriazin
Chemical compound
which acts as a small-molecule antagonist of the previously orphan receptor GPR139. It has been shown to modulate dopamine release in the brain via interaction
JNJ-3792165
Pharmaceutical compound
of the previously orphan receptor GPR139. It has been used to investigate the structure and function of the GPR139 receptor, and its interactions with
TC-O_9311
Protein-coding gene in the species Homo sapiens, named for ketazocine
peptides as the primary endogenous ligands, the other being newly deorphanized GPR139 receptor. In addition, oxytocin was found to be a positive allosteric modulator
Κ-opioid_receptor
Pharmaceutical compound
small-molecule agonist of the previously orphan receptor GPR139. It has been used to investigate the role of GPR139 in various behavioral processes including sleep
JNJ-63533054
Trace amine
in animals. Tryptamine has been found to act as a potent agonist of the GPR139 and to be involved in sleep regulation. In a published clinical study, tryptamine
Tryptamine
Investigational cognition and memory disorder drugs
– klotho modulator [115] Zelatriazin (TAK-041; NBI-1065846; NBI-846) – GPR139 agonist [116] Zervimesine (CT-1812; Elayta) – sigma σ2 receptor antagonist
List of investigational cognition and memory disorder drugs
List_of_investigational_cognition_and_memory_disorder_drugs
List of pharmaceutical drugs under clinical development for treatment of depression
Zelatriazin (TAK-041; NBI-1065846; NBI-846) – G protein-coupled receptor 139 (GPR139) agonist Ziprasidone (Geodon) – atypical antipsychotic (non-selective monoamine
List of investigational antidepressants
List_of_investigational_antidepressants
Q96N19 6557 GPR137B HGNC:11862; O60478 6558 GPR137C HGNC:25445; Q8N3F9 6559 GPR139 HGNC:19995; Q6DWJ6 6560 GPR141 HGNC:19997; Q7Z602 6561 GPR142 HGNC:20088;
List of human protein-coding genes 3
List_of_human_protein-coding_genes_3
Investigational antipsychotics
psychotic disorders [250] Zelatriazin (TAK-041; NBI-1065846; NBI-846) – GPR139 agonist – schizophrenia [251] Chlorpromazine (Thorazine, Largactil) – dopamine
List of investigational antipsychotics
List_of_investigational_antipsychotics
travel, tourism, insurance
GPR139
GPR139
GPR139
GPR139
GPR139
GPR139
GPR139
GPR139
GPR139
travel, tourism, insurance